Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5208578
Max Phase: Preclinical
Molecular Formula: C9H11N5
Molecular Weight: 189.22
Associated Items:
ID: ALA5208578
Max Phase: Preclinical
Molecular Formula: C9H11N5
Molecular Weight: 189.22
Associated Items:
Canonical SMILES: Cc1[nH]nc2c(NC3CC3)ncnc12
Standard InChI: InChI=1S/C9H11N5/c1-5-7-8(14-13-5)9(11-4-10-7)12-6-2-3-6/h4,6H,2-3H2,1H3,(H,13,14)(H,10,11,12)
Standard InChI Key: CTRMXAARLMLINT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 189.22 | Molecular Weight (Monoisotopic): 189.1014 | AlogP: 1.24 | #Rotatable Bonds: 2 |
Polar Surface Area: 66.49 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.40 | CX Basic pKa: 0.93 | CX LogP: 0.85 | CX LogD: 0.85 |
Aromatic Rings: 2 | Heavy Atoms: 14 | QED Weighted: 0.75 | Np Likeness Score: -1.45 |
1. Nai F, Nachawati R, Zálešák F, Wang X, Li Y, Caflisch A.. (2022) Fragment Ligands of the m6A-RNA Reader YTHDF2., 13 (9.0): [PMID:36110386] [10.1021/acsmedchemlett.2c00303] |
Source(1):